Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renoprotection”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)UnknownNCT01377285
What this trial is testing

Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Renal Failure
National Taiwan University Hospital 350
Post-approval studies (Phase 4)Study completedNCT00573430
What this trial is testing

ARIA (Atacand Renoprotection In NephropAthy Pt.)

Who this might be right for
Non-diabetic Nephropathy With Hypertension
AstraZeneca 128
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Large-scale testing (Phase 3)UnknownNCT04251351
What this trial is testing

Effect of Paracetamol on Kidney Function in Severe Malaria

Who this might be right for
Severe MalariaMalaria,FalciparumAcute Kidney Injury+1 more
University of British Columbia 460
Post-approval studies (Phase 4)Study completedNCT02106104
What this trial is testing

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 48
Post-approval studies (Phase 4)UnknownNCT03433248
What this trial is testing

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES

Who this might be right for
Type2 Diabetes
M.H.H. Kramer 66
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Not applicableEnded earlyNCT00338091
What this trial is testing

Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

Who this might be right for
Renal Insufficiency,ChronicDisease ProgressionProteinuria+3 more
Southern Medical University, China
Large-scale testing (Phase 3)Study completedNCT00340678
What this trial is testing

Renoprotection in Early Diabetic Nephropathy in Pima Indians

Who this might be right for
Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 170
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143
What this trial is testing

ProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor
Amsterdam UMC 784
Post-approval studies (Phase 4)Study completedNCT00317954
What this trial is testing

Spironolactone in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Steno Diabetes Center Copenhagen 48
Post-approval studies (Phase 4)Study completedNCT00320879
What this trial is testing

Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

Who this might be right for
Type 2 DiabetesMicroalbuminuria
Steno Diabetes Center Copenhagen 52